Teva Pharmaceutical Industries (Teva Pharmaceutical Industries) Accounts Payable & Accrued Expense : $5,373 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Teva Pharmaceutical Industries Accounts Payable & Accrued Expense?

Teva Pharmaceutical Industries's quarterly accounts payable & accrued expense increased from Jun. 2023 ($5,006 Mil) to Sep. 2023 ($5,021 Mil) and increased from Sep. 2023 ($5,021 Mil) to Dec. 2023 ($5,373 Mil).

Teva Pharmaceutical Industries's annual accounts payable & accrued expense increased from Dec. 2021 ($3,894 Mil) to Dec. 2022 ($4,038 Mil) and increased from Dec. 2022 ($4,038 Mil) to Dec. 2023 ($5,373 Mil).

Teva Pharmaceutical Industries Accounts Payable & Accrued Expense Historical Data

The historical data trend for Teva Pharmaceutical Industries's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teva Pharmaceutical Industries Accounts Payable & Accrued Expense Chart

Teva Pharmaceutical Industries Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

3,587.00

3,536.00

3,894.00

4,038.00

5,373.00

Teva Pharmaceutical Industries Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															4,038.00	4,648.00	5,006.00	5,021.00	5,373.00

Teva Pharmaceutical Industries Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Teva Pharmaceutical Industries (Teva Pharmaceutical Industries) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teva Pharmaceutical Industries Ltd (OTCPK:TEVJF) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

TEVA:USA TEVA:Mexico TEVA:Israel 0LER:UK TEV:Germany TEV:Germany TEV:Germany T1EV34:Brazil TEVA:Austria

Address

124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020

Website

https://www.tevapharm.com

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the U.S. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a U.S.-based generic and specialty drug distributor.